Treatment of Streptococcus saprophyticus UTI
For uncomplicated cystitis caused by Staphylococcus saprophyticus, use nitrofurantoin 100 mg twice daily for 5 days as first-line therapy, or alternatively fosfomycin 3g single dose (women only), pivmecillinam 400 mg three times daily for 3-5 days, or trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days if local resistance is <20%. 1
First-Line Treatment Options
The 2024 European Association of Urology guidelines provide clear first-line regimens for uncomplicated cystitis that are effective against S. saprophyticus 1:
- Nitrofurantoin: 100 mg twice daily for 5 days (multiple formulations available)
- Fosfomycin trometamol: 3g single dose (women only)
- Pivmecillinam: 400 mg three times daily for 3-5 days
Recent 2025 research demonstrates that pivmecillinam achieves urinary concentrations of ~200 mg/L, which exceeds the MIC cluster of 32-64 mg/L for most S. saprophyticus isolates, explaining its clinical success despite traditionally being considered "non-susceptible" 2. Clinicians should not switch empirical pivmecillinam treatment based solely on S. saprophyticus identification 2.
Alternative Agents
When first-line options are unavailable or contraindicated 1:
- Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 3 days (if local E. coli resistance <20%)
- Cephalosporins (e.g., cefadroxil 500 mg twice daily for 3 days): Use only if local resistance <20%
Critical Pitfalls to Avoid
Beta-Lactam Resistance Issues
Approximately 45-60% of S. saprophyticus isolates demonstrate oxacillin resistance, making many oral beta-lactams unreliable 3, 4. This is particularly problematic because:
- Ceftriaxone shows high MICs (4 to >32 μg/mL) against S. saprophyticus compared to S. aureus (1.5-4 μg/mL) 3
- Many UTIs are inappropriately treated with beta-lactams: 60% of cystitis cases and 25% of pyelonephritis cases receive ineffective regimens 3
- This is especially concerning in pregnancy, where fluoroquinolones and trimethoprim-sulfamethoxazole have restrictions 4
Fluoroquinolone Considerations
While fluoroquinolones show excellent susceptibility (>99% susceptible, with only 0.9-1.5% resistance) 4, 5, they should be reserved for more serious infections due to ecological concerns and adverse effects 1, 6. For uncomplicated cystitis, ciprofloxacin 3 days is effective but not preferred first-line 6.
Treatment Duration by Syndrome
For uncomplicated cystitis 6:
- Nitrofurantoin: 5 days
- Fosfomycin: Single dose
- Pivmecillinam: 3 days
- TMP/SMX: 3 days
- Fluoroquinolones: 3 days
For pyelonephritis caused by S. saprophyticus 6:
- Beta-lactams: 7 days (though efficacy questionable given resistance patterns)
- Fluoroquinolones: 5-7 days
Special Populations
Pregnant Women
S. saprophyticus commonly affects women aged 15-44 years, including pregnant patients 4. In pregnancy:
- Amoxicillin-clavulanic acid shows 100% susceptibility 4 and is pregnancy-safe
- Avoid TMP/SMX in first and third trimesters 1
- Nitrofurantoin is generally safe except near term
- Avoid fluoroquinolones (FDA Category C) 4
Men
For men with uncomplicated UTI, use TMP/SMX 160/800 mg twice daily for 7 days (longer duration than women) 1. Fluoroquinolones can be prescribed according to local susceptibility 1.
Antimicrobial Susceptibility Patterns
All S. saprophyticus isolates remain susceptible to 5:
- Nitrofurantoin (100%)
- Ciprofloxacin (100%)
- Rifampin (100%)
- Linezolid (100%)
- Trimethoprim-sulfamethoxazole (95%)
High resistance observed to 4:
- Penicillin (55.6%)
- Erythromycin (37.7%)
- Oxacillin (45%)
When to Obtain Cultures
Urine culture is recommended for 1:
- Suspected pyelonephritis
- Symptoms not resolving or recurring within 4 weeks
- Atypical symptoms
- Pregnancy
Do not perform routine post-treatment cultures in asymptomatic patients 1. If symptoms persist or recur within 2 weeks, obtain culture and assume resistance to the initial agent; retreat with a different 7-day regimen 1.